- OLED manufacturing capacities will be expanded at the Pyeongtaek and Shanghai sites
- Additional OLED sublimation units will help meet customer demand in the growing OLED market of Asia
Merck, a leading science and technology company, today announced a € 20 million expansion of its OLED (organic light-emitting diode) manufacturing capacity at its sites in Pyeongtaek, Korea and Shanghai, China. Additional sublimation units will be built to help meet customer demand in the growing OLED market. With the investment, Merck will further increase its local OLED production footprint in Korea and establish OLED production capacity in China. The enhanced local manufacturing capacities will strengthen the company's position as key supplier of high-purity OLED materials for panel makers in Asia. With its Performance Materials business sector, Merck is a leading player in the electronic materials market and OLED materials are one of the defined investment focus areas for future growth.
"OLED technology is the fastest growing display technology enabling next-generation displays", said Kai Beckmann, Member of the Executive Board of Merck and CEO Performance Materials. "By expanding our local manufacturing capacities, we're well positioned to efficiently produce and deliver higher volumes of OLED materials. This investment underscores our commitment to creating an agile supply chain for our customers in Asia."
The € 20 million investment will be used to build a new modular production system that facilitates the installation of additional sublimation units in line with market requirements. Sublimation processes are key to ensure the highest quality of OLED materials. The purity of OLED materials is one of the most important factors affecting the performance and lifetime of OLED devices.
As new form factors enabled by OLED technology - such as foldable and rollable displays - continue to penetrate the market, Merck is expanding its OLED manufacturing capacities in Asia to meet the increasing demand for high-purity OLED materials.
With research activities dating back three decades as well as early investments in OLED manufacturing capacities, Merck is well positioned as a leading global material supplier of this technology. In 2010, Merck established an OLED Research Center at its global headquarters in Darmstadt, Germany. In 2015, the company inaugurated an OLED Application Center (OAC) in Pyeongtaek, Korea. In 2016, Merck opened an additional production plant for OLED materials in Darmstadt, Germany. Since 2018, the company has also been supporting Chinese customers in its OLED Technology Center (OTC) in Shanghai, China.
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices - the company is everywhere. In 2019, Merck generated sales of € 16.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.
For information about healthcare and printed electronics research from IDTechEx, please visit www.IDTechEx.com/research or contact us at Research@IDTechEx.com.
- Flexible, Printed OLED Displays 2020-2030: Forecasts, Markets, Technologies
- Flexible, Printed and Organic Electronics 2020-2030: Forecasts, Technologies, Markets
- AI in Medical Diagnostics 2020-2030: Image Recognition, Players, Clinical Applications, Forecasts
- Digital Health & Artificial Intelligence 2020: Trends, Opportunities, and Outlook
- Flexible Electronics in Healthcare 2020-2030
- COVID-19 Diagnostics